Vagus Nerve Stimulator Market By Product Type (Implantable Vagus Nerve Stimulator, Transcutaneous Vagus Nerve Stimulator (External)), By Application (Pain Management, epression & Anxiety, Epilepsy, Obesity, Others (Obstructive Sleep Apnea, Opioid Withdrawal)), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers) - Growth, Future Prospects, and Competitive Analysis, 2019 - 2027
"Prevalence of neurological disorders has risen significantly on a global scale"
The global vagus nerve stimulator market is growing competently, expected to grow at a CAGR of 7.4%. Globally, increasing open and minimally invasive neurological surgeries along with VNS therapies has significantly increased the revenue of vagus nerve stimulator devices. Increasing population globally, costs of medical expenditure for stroke and dementia, burden of dyskinesia and neurological tremors and new technology expansion will enhance the growth of the global vagus nerve stimulator market.
"Implantable VNS segment is expected to register higher growth by the end of 2027"
In June 2017, FDA approved LivaNova's vagus nerve stimulation therapy system for epilepsy in children as young as four years. Utilization of implantable VNS devices is associated with abnormal complexities such as dysrhythmia, paresthesia, cough, voice alteration, pain, and surgically related infections. New and advanced vagus nerve stimulation devices (external) have been approved in Europe to treat depression, epilepsy, and pain. A similar noninvasive device was recently approved by the FDA for the treatment of cluster headaches in the U.S. FDA approval of new products, higher efficacy of implantable devices, increasing applications for epilepsy, along with awareness, offers potential advantage as an elective treatment to high-cost surgical procedures.
"Epilepsy segment is expected to register higher growth by the end of 2027"
The global market is witnessing a gradual shift towards modern VNS devices, the demand for minimally invasive procedures has been rising over the past five years. Enhanced applications for partial epilepsy (aged 12 and older), generalized epilepsy, Lennox-Gastaut syndrome (LGS) will drive the market growth. Development in the field of VNS therapy along with the usage and benefits for external device stimulation will enhance the market growth. Vagus nerve stimulator devices can be utilized for normalizing other neurological conditions such as Crohn's disease, migraines, Asthma, headaches depression, and numerous cardiovascular diseases.
"Increasing hospital admissions, rising medical expenditure and the presence of top companies holds the U.S. in dominant position"
In 2018, the U.S. generated maximum revenue in the vagus nerve stimulator market due to an increase in prevalence for neurological disorders. The market in this region is driven by the significant prevalence of neurological disorders such as Parkinson’s disease, Alzheimer’s disease, depression, spinal cord injury, epilepsy, and traumatic brain injury in the U.S. market. Increasing procedures for intractable epilepsy and treatment-resistant depression along with technology advancement in minimally invasive surgery will drive the market growth. New technology expansion in the developing nations (mainly in the Asia Pacific region), higher patient pool for brain-related disorders along with surgery, enhanced applications for epileptic seizures, pain management, tinnitus, and depression & anxiety will drive the demand for implantable VNS devices in the near future.
"Increased research and development with strong product portfolio in the developed regions"
Major players in the vagus nerve stimulator market are Medtronic Plc., LivaNova Plc. BioControl Medical, EnteroMedics Inc., NERVANA LLC., ElectroCore LLC, Cerbomed GmbH, ReShape Lifesciences, Inc, Parasym Health, Innovative Health Solutions INC, Beijing PINS Medical Co., Ltd., Aleva Neurotherapeutics SA, and others. Major implantable VNS device and external VNS device manufacturers are focused on producing top quality products with enhanced biomaterials. Partnerships, product launch, and improved R&D will upsurge the development of the vagus nerve stimulation in the near future.
Historical & Forecast Period
This study report represents analysis for each segment from 2017 to 2027 considering 2018 to be the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period from 2019 to 2027.
Report Scope by Segments
Market Segmentation
| ATTRIBUTE | DETAILS |
|---|---|
| Research Period | 2017-2027 |
| Base Year | 2018 |
| Forecast Period | 2019-2027 |
| Historical Year | 2017 |
| Unit | USD Million |
| Segmentation |
Product Type (2017–2027; US$ Mn) |
|
Application (2017–2027; US$ Mn) |
|
|
End-User (2017–2027; US$ Mn) |
|
|
Geography (2017–2027; US$ Mn) |
The current report also comprehends qualitative and qualitative market valuation factors such as key market drivers, market trends, restraints and opportunities that give a better market understanding of the overall vagus nerve stimulator market. Additionally, the global report also comprises graphical representation of competitive landscape based on their market initiatives and strategies, product portfolio and business strengths.
Key questions answered in this report
- What are the current market trends and dynamics in the vagus nerve stimulator market and valuable opportunities for emerging players?
- Which segment accounts for the fastest CAGR during the forecast period?
- Which product type segment holds a larger market share and why?
- Are low and middle-income economies investing in the vagus nerve stimulator market?
- What is the market trend and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Market Segmentation
1.3. Research Scope
1.4. Research Methodology
1.4.1. Phase I – Secondary Research
1.4.2. Phase II – Primary Research
1.4.3. Phase III – Expert Panel Review
1.4.4. Assumptions
1.5. Market Segmentation
Chapter 2. Executive Summary
2.1. Global VNS Market Portraiture
2.2. Global VNS Market, By Product Type, 2018 (US$ Mn)
2.3. Global VNS Market, By Application, 2018 (US$ Mn)
2.4. Global VNS Market, By End User, 2018 (US$ Mn)
2.5. Global VNS Market, by Geography, 2018 vs. 2027 (Value %)
Chapter 3. Global VNS Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. VNS Market Technologies: Future Trends
3.3. Current Scenario: New Product Launches, Technology Expansion
3.4. Challenges
3.5. Opportunities
3.6. Attractive Investment Proposition, by Geography, 2018
3.7. Competitive Landscape
3.7.1. Competitive Landscape, by Key Players, 2018
Chapter 4. Global Vagus Nerve Stimulator (VNS) Market, by Product Type, 2017 – 2027 (US$ Mn)
4.1. Overview
4.2. Implantable VNS
4.3. Transcutaneous VNS (External)
Chapter 5. Global Vagus Nerve Stimulator (VNS) Market, by Application, 2017 – 2027 (US$ Mn)
5.1. Overview
5.2. Pain Management
5.3. Depression & Anxiety
5.4. Epilepsy
5.5. Obesity
5.6. Others (Obstructive Sleep Apnea, Opoid Withdrawal)
Chapter 6. Global Vagus Nerve Stimulator (VNS) Market, By End User, 2017 – 2027 (US$)
6.1. Overview
6.2. Hospitals
6.3. Specialty Clinics
6.4. Ambulatory Surgical Centers
Chapter 7. Global Vagus Nerve Stimulator (VNS) Market, by Geography, 2017 – 2027 (US$ Mn)
7.1. Overview
7.2. North America VNS Market Analysis, 2017 – 2027
7.2.1. North America VNS Market, By Product Type, 2017 – 2027 (US$ Mn)
7.2.2. North America VNS Market, By Application, 2017 – 2027 (US$ Mn)
7.2.3. North America VNS Market, By End User, 2017 – 2027 (US$ Mn)
7.2.4. North America VNS Market, by Country, 2017 – 2027 (US$ Mn)
7.2.4.1. U.S.
7.2.4.2. Canada
7.3. Europe VNS Market Analysis, 2017 – 2027
7.3.1. Europe VNS Market, By Product Type, 2017 – 2027 (US$ Mn)
7.3.2. Europe VNS Market, By Application, 2017 – 2027 (US$ Mn)
7.3.3. Europe VNS Market, By End User, 2017 – 2027 (US$ Mn)
7.3.4. Europe VNS Market, by Country, 2017 – 2027 (US$ Mn)
7.3.4.1. U.K.
7.3.4.2. Germany
7.3.4.3. Rest of Europe
7.4. Asia Pacific VNS Market Analysis, 2017 – 2027
7.4.1. Asia Pacific VNS Market, By Product Type, 2017 – 2027 (US$ Mn)
7.4.2. Asia Pacific VNS Market, By Application, 2017 – 2027 (US$ Mn)
7.4.3. Asia Pacific VNS Market, By End User, 2017 – 2027 (US$ Mn)
7.4.4. Asia Pacific VNS Market, by Country, 2017 – 2027 (US$ Mn)
7.4.4.1. Japan
7.4.4.2. China
7.4.4.3. Rest of APAC
7.5. Latin America VNS Market Analysis, 2017 – 2027
7.5.1. Latin America VNS Market, By Product Type, 2017 – 2027 (US$ Mn)
7.5.2. Latin America VNS Market, By Application, 2017 – 2027 (US$ Mn)
7.5.3. Latin America VNS Market, By End User, 2017 – 2027 (US$ Mn)
7.5.4. Latin America VNS Market, by Country, 2017 – 2027 (US$ Mn)
7.5.4.1. Brazil
7.5.4.2. Mexico
7.5.4.3. Rest of Latin America
7.6. Middle East & Africa (MEA) VNS Market Analysis, 2017 – 2027
7.6.1. MEA VNS Market, by Product Type, 2017 – 2027 (US$ Mn)
7.6.2. MEA VNS Market, by Application, 2017 – 2027 (US$ Mn)
7.6.3. MEA VNS Market, By End User, 2017 – 2027 (US$ Mn)
7.6.4. MEA VNS Market, by Region, 2017 – 2027 (US$ Mn)
7.6.4.1. GCC
7.6.4.2. Rest of MEA
Chapter 8. Company Profiles
8.1. Medtronic Plc.
8.1.1. Business Description
8.1.2. Financial InFormation (Subject to data availability)
8.1.3. Product Portfolio
8.1.4. Key Developments
8.2. LivaNova Plc.
8.3. BioControl Medical
8.4. EnteroMedics Inc.
8.5. NERVANA LLC.
8.6. ElectroCore LLC
8.7. Cerbomed GmbH
8.8. ReShape Lifesciences, Inc
8.9. Parasym Health
8.10. Innovative Health Solutions INC
8.11. Beijing PINS Medical Co., Ltd.
8.12. Aleva Neurotherapeutics SA
* Here we are using VNS as a short form of Vagus Nerve Stimulator
TABLE 1 Market Snapshot: Global Vagus Nerve Stimulator (VNS) Market
TABLE 2 Global VNS Market, by Product Type, 2017–2027 (US$ Mn)
TABLE 3 Global VNS Market, by Application, 2017–2027 (US$ Mn)
TABLE 4 Global VNS Market, by End User, 2017–2027 (US$ Mn)
TABLE 5 Global VNS Market, by Geography, 2017–2027 (US$ Mn)
TABLE 6 North America VNS Market, by Product Type, 2017–2027 (US$ Mn)
TABLE 7 North America VNS Market, by Application, 2017–2027 (US$ Mn)
TABLE 8 North America VNS Market, by End User, 2017–2027 (US$ Mn)
TABLE 9 North America VNS Market, by Country, 2017–2027 (US$ Mn)
TABLE 10 Europe VNS Market, by Product Type, 2017–2027 (US$ Mn)
TABLE 11 Europe VNS Market, by Application, 2017–2027 (US$ Mn)
TABLE 12 Europe VNS Market, by End User, 2017–2027 (US$ Mn)
TABLE 13 Europe VNS Market, by Country/Region, 2017–2027 (US$ Mn)
TABLE 14 Latin America VNS Market, by Product Type, 2017–2027 (US$ Mn)
TABLE 15 Latin America VNS Market, by Application, 2017–2027 (US$ Mn)
TABLE 16 Latin America VNS Market, by End User, 2017–2027 (US$ Mn)
TABLE 17 Latin America VNS Market, by Country/Region, 2017–2027 (US$ Mn)
TABLE 18 Asia Pacific VNS Market, by Product Type, 2017–2027 (US$ Mn)
TABLE 19 Asia Pacific VNS Market, by Application, 2017–2027 (US$ Mn)
TABLE 20 Asia Pacific VNS Market, by End User, 2017–2027 (US$ Mn)
TABLE 21 Asia Pacific VNS Market, by Country/Region, 2017–2027 (US$ Mn)
TABLE 22 Middle East & Africa VNS Market, by Product Type, 2017–2027 (US$ Mn)
TABLE 23 Middle East & Africa VNS Market, by Application, 2017–2027 (US$ Mn)
TABLE 24 Middle East & Africa VNS Market, by End User, 2017–2027 (US$ Mn)
TABLE 25 Middle East & Africa VNS Market, by Region, 2017–2027 (US$ Mn)
TABLE 26 Medtronic Plc.: Company Snapshot (Company Overview; Product Portfolio; Financial InFormation; Key Developments)
TABLE 27 LivaNova Plc.: Company Snapshot (Company Overview; Product Portfolio; Financial InFormation; Key Developments)
TABLE 28 BioControl Medical: Company Snapshot (Company Overview; Product Portfolio; Financial InFormation; Key Developments)
TABLE 29 EnteroMedics Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial InFormation; Key Developments)
TABLE 30 NERVANA LLC.: Company Snapshot (Company Overview; Product Portfolio; Financial InFormation; Key Developments)
TABLE 31 ElectroCore LLC: Company Snapshot (Company Overview; Product Portfolio; Financial InFormation; Key Developments)
TABLE 32 Cerbomed GmbH: Company Snapshot (Company Overview; Product Portfolio; Financial InFormation; Key Developments)
TABLE 33 ReShape Lifesciences, Inc: Company Snapshot (Company Overview; Product Portfolio; Financial InFormation; Key Developments)
TABLE 34 Parasym Health: Company Snapshot (Company Overview; Product Portfolio; Financial InFormation; Key Developments)
TABLE 35 Innovative Health Solutions INC: Company Snapshot (Company Overview; Product Portfolio; Financial InFormation; Key Developments)
TABLE 36 Beijing PINS Medical Co., Ltd.: Company Snapshot (Company Overview; Product Portfolio; Financial InFormation; Key Developments)
TABLE 37 Aleva Neurotherapeutics SA: Company Snapshot (Company Overview; Product Portfolio; Financial InFormation; Key Developments)
FIG. 1 Global Vagus Nerve Stimulator (VNS) Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global VNS Market Segmentation
FIG. 4 Global VNS Market, by Product Type, 2017 (US$ Mn)
FIG. 5 Global VNS Market, by Application, 2017 (US$ Mn)
FIG. 6 Global VNS Market, by End User, 2017 (US$ Mn)
FIG. 7 Global VNS Market, by Geography, 2017 (US$ Mn)
FIG. 8 Attractive Investment Proposition, by Geography, 2017
FIG. 9 Global Market Positioning of Key VNS Market Manufacturers, 2018
FIG. 10 Global Implantable VNS Market, 2017–2027 (US$ Mn)
FIG. 11 Global Transcutaneous VNS (External) Market, 2017–2027 (US$ Mn)
FIG. 12 Global VNS Market For Pain Management, 2017–2027 (US$ Mn)
FIG. 13 Global VNS Market For Depression & Anxiety, 2017–2027 (US$ Mn)
FIG. 14 Global VNS Market For Epilepsy, 2017–2027 (US$ Mn)
FIG. 15 Global VNS Market For Obesity, 2017–2027 (US$ Mn)
FIG. 16 Global VNS Market For Others (Obstructive Sleep Apnea, Opoid Withdrawal), 2017–2027 (US$ Mn)
FIG. 17 Global Hospitals Market For VNS, 2017–2027 (US$ Mn)
FIG. 18 Global Specialty Clinics Market For VNS, 2017–2027 (US$ Mn)
FIG. 19 Global Ambulatory Surgical Centers Market For VNS, 2017–2027 (US$ Mn)
FIG. 20 U.S. VNS Market, 2017–2027 (US$ Mn)
FIG. 21 Canada VNS Market, 2017–2027 (US$ Mn)
FIG. 22 U.K. VNS Market, 2017–2027 (US$ Mn)
FIG. 23 Germany VNS Market, 2017–2027 (US$ Mn)
FIG. 24 Rest of Europe VNS Market, 2017–2027 (US$ Mn)
FIG. 25 Japan VNS Market, 2017–2027 (US$ Mn)
FIG. 26 China VNS Market, 2017–2027 (US$ Mn)
FIG. 27 Rest of Asia Pacific VNS Market, 2017–2027 (US$ Mn)
FIG. 28 Brazil VNS Market, 2017–2027 (US$ Mn)
FIG. 29 Mexico VNS Market, 2017–2027 (US$ Mn)
FIG. 30 Rest of Latin America VNS Market, 2017–2027 (US$ Mn)
FIG. 31 GCC VNS Market, 2017–2027 (US$ Mn)
FIG. 32 Rest of Middle East & Africa VNS Market, 2017–2027 (US$ Mn)
Choose License
Contact Information
: sales@briskinsights.com
: +448081890034 (UK)